Perpetua Medical AB (publ) (STO:PERP.B)
Sweden · Delayed Price · Currency is SEK 3.490
-0.150 (-4.12%)
Jul 24, 2026, 1:03 PM CET
Perpetua Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28.87 | 26.51 | 14.15 | 9.98 | 10.42 | 9 | |
Revenue Growth (YoY) | 179.58% | 87.30% | 41.75% | -4.16% | 15.80% | 225.16% |
Cost of Revenue | 2.8 | 6.96 | 3.8 | 4.09 | 3.47 | 2.89 |
Gross Profit | 26.07 | 19.55 | 10.35 | 5.89 | 6.95 | 6.11 |
Selling, General & Admin | 12.81 | 14.89 | 10.94 | 23.78 | 25.56 | 19.37 |
Depreciation & Amortization Expenses | 3.4 | 2.5 | 0.32 | 0.18 | 0.39 | 0.38 |
Other Operating Expenses | 0.12 | 0.11 | 1.55 | 0.43 | 0.11 | 0.04 |
Total Operating Expenses | 16.32 | 17.51 | 12.81 | 24.39 | 26.06 | 19.79 |
Operating Income | 0.19 | 2.04 | -2.46 | -18.49 | -19.11 | -13.68 |
Interest Income | 0.32 | 0.08 | 0.29 | 0.29 | 0.07 | 0.12 |
Interest Expense | -0.8 | -0.7 | -0.08 | -0.07 | -0.13 | -0.15 |
Other Non-Operating Income (Expense) | -0.23 | -0.23 | 0.04 | 0 | - | - |
Total Non-Operating Income (Expense) | -0.71 | -0.85 | 0.25 | 0.22 | -0.05 | -0.03 |
Pretax Income | -0.52 | 1.19 | -2.2 | -18.28 | -19.16 | -13.71 |
Provision for Income Taxes | -0.2 | -0.02 | 0.18 | 0 | - | - |
Net Income | 2.46 | 1.22 | -2.38 | -18.28 | -19.16 | -13.71 |
Minority Interest in Earnings | 2.02 | 1.24 | -0.09 | 0 | - | - |
Net Income to Common | 1.7 | 2.45 | -2.47 | -18.28 | -19.16 | -13.71 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 5 | 4 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 6 | 5 | 4 | 3 | 1 | 1 |
Shares Change (YoY) | 25.04% | 9.65% | 53.11% | 280.74% | 28.50% | 20.91% |
EPS (Basic) | 0.21 | 0.26 | -0.56 | -10.58 | -27.60 | -24.72 |
EPS (Diluted) | 0.21 | 0.26 | -0.56 | -10.58 | -27.60 | -24.72 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -6.5 | -6.53 | -7.03 | -16.41 | -19.65 | -15.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.15 | -1.40 | -1.65 | -5.92 | -26.97 | -27.94 |
Gross Margin | 90.29% | 73.75% | 73.17% | 59.04% | 66.71% | 67.91% |
Operating Margin | 0.67% | 7.71% | -17.35% | -185.22% | -183.44% | -152.11% |
Profit Margin | 8.53% | 4.58% | -16.83% | -183.07% | -183.97% | -152.42% |
FCF Margin | -22.50% | -24.65% | -49.65% | -164.38% | -188.65% | -176.08% |
EBITDA | 0.19 | 2.04 | -2.46 | -18.31 | -19.11 | -13.68 |
EBITDA Margin | 0.67% | 7.71% | -17.35% | -183.43% | -183.44% | -152.11% |
EBIT | 0.19 | 2.04 | -2.46 | -18.49 | -19.11 | -13.68 |
EBIT Margin | 0.67% | 7.71% | -17.35% | -185.22% | -183.44% | -152.11% |
Effective Tax Rate | 38.32% | -1.92% | -8.03% | 0.00% | 0.00% | 0.00% |